Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2ACTEMRA

02 1ARGATROBAN IN SODIUM CHLORIDE

03 2COSENTYX

04 1DARZALEX

05 1FOLLISTIM AQ

06 1GONAL-F RFF REDI-JECT

07 1KINEVAC

08 1MIRCERA

09 1MUPIROCIN

10 1PRIALT

11 1SINCALIDE

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

PEGS Boston Summit
Not Confirmed
arrow

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

ARGATROBAN

Drug : ARGATROBAN IN SODIUM CHLORIDE

Dosage Form : INJECTABLE; INTRAVENOUS

Application Number : 22434

Country : US

Patented : Yes

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FOLLITROPIN ALFA/BETA

Drug : GONAL-F RFF REDI-JECT

Dosage Form : INJECTABLE; SUBCUTANEOUS

Application Number : 21684

Country : US

Patented : No

blank

04

PEGS Boston Summit
Not Confirmed
arrow

06

PEGS Boston Summit
Not Confirmed
arrow

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

TOCILIZUMAB

Drug : ACTEMRA

Dosage Form : INJECTABLE; INTRAVENOUS, SUBCUTANEOUS

Application Number : 125472

Country : US

Patented : No

blank

08

PEGS Boston Summit
Not Confirmed
arrow

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DARATUMUMAB

Drug : DARZALEX

Dosage Form : INJECTABLE; INJECTION

Application Number : 761036

Country : US

Patented : No

blank

10

PEGS Boston Summit
Not Confirmed
arrow